V CompBrief BY VELARION

Independent Director · Kura Oncology, Inc. (KURA)

Chair, Audit Committee

Carol Schafer director compensation at Kura Oncology (FY2025): $186K

Fiscal year 2025 director compensation for Carol Schafer at Kura Oncology, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 10, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Carol Schafer’s full pay file as a PDF — free

More than this page: up to 10 years of Carol’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Carol Schafer and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Kura Oncology Director Compensation Table · all 4 fiscal years held
In US dollars, as Kura Oncology reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$70,215$0$116,035$0$186,250
FY2024$65,000—$341,071—$406,071
FY2022$55,000—$225,911—$280,911
FY2021$30,509—$944,661—$975,170

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Kura Oncology, Inc. DEF 14A filed April 10, 2026, accession 0001193125-26-151335, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Kura Oncology, Inc. filed document, accession 0001193125-26-151335. Every figure is read from that document and cited to the page and table it appears in. Filed April 10, 2026.

Get the Kura Oncology Board Governance Report

$186,250 Carol Schafer, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 10, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Kura Oncology pays directors a $45,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Audit (Chair) · Nominating/Governance

The rest of the Kura Oncology board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Diane ParksIndependent Director$173,750
Faheem HasnainIndependent Director$206,250
Helen Collins, M.DIndependent Director$173,750
Mary T. SzelaIndependent Director$186,250
Michael Vasconcelles, M.DIndependent Director$168,750
Thomas MalleyIndependent Director$181,250
Troy E. Wilson, Ph.D., J.DChair of the Board—

The full Kura Oncology compensation record

free company brief
Kura Oncology, Inc. (KURA) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within Kura Oncology's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Kura Oncology proxy · each links to its own free brief

Order KURA

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report